Bayer Cropscience India Limited AI Stock Analysis
Want to see IN:BAYERCROP full AI Analyst Report?
Bayer Cropscience India Limited (BAYERCROP) AI Stock Analysis
Bayer Cropscience India Limited
(NSE:BAYERCROP)
The overall score is driven primarily by Bayer CropScience India’s high‑quality financial profile, combining strong growth, solid margins, and a very conservative balance sheet, which together support a lower‑risk earnings base. Valuation is supportive but not deeply discounted, with a mid‑range P/E offset by an attractive dividend yield, making the stock reasonably priced for its fundamentals. Technicals currently show a mild downtrend and subdued momentum, which slightly tempers the otherwise strong fundamental and valuation picture.
Bayer Cropscience India Limited (BAYERCROP) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 150.09B
- Dividend Yield
- 4.48%
- Average Volume (3M)
- 6,125
- Price to Earnings (P/E)
- 20.2
- Beta (1Y)
- 0.78
- Revenue Growth
- -5.00%
- EPS Growth
- 22.45%
- Country
- India
- Employees
- 1,317
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Agricultural Inputs
Bayer Cropscience India Limited Business Overview & Revenue Model
Company Description
Bayer CropScience Limited, founded in Thane, India, in 1958, is a diversified enterprise involved in various sectors, including agriculture, pharmaceuticals, and consumer health, with a global reach encompassing India, Germany, and Bangladesh, among...
Bayer Cropscience India Limited Financial Statement Overview
Summary
Financial performance is very strong, driven by robust profitability, healthy double‑digit margins, and a conservative balance sheet with low debt, offset only by some margin pressure and volatile but generally solid cash generation.
Income Statement
86Very PositiveBalance Sheet
92Very PositiveCash Flow
78Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.93B | 56.75B | 54.73B | 51.06B | 51.40B | 47.34B |
| Gross Profit | 20.93B | 17.65B | 20.59B | 21.81B | 23.09B | 20.57B |
| EBITDA | 10.57B | 9.69B | 6.92B | 9.79B | 9.27B | 8.15B |
| Net Income | 7.46B | 6.89B | 5.68B | 7.41B | 7.58B | 6.45B |
Balance Sheet | ||||||
| Total Assets | 55.37B | 56.99B | 52.46B | 45.97B | 46.79B | 43.53B |
| Cash, Cash Equivalents and Short-Term Investments | 5.42B | 14.79B | 9.29B | 12.11B | 9.02B | 8.19B |
| Total Debt | 704.00M | 818.00M | 1.05B | 471.00M | 735.00M | 864.00M |
| Total Liabilities | 23.53B | 27.34B | 23.95B | 17.48B | 19.66B | 18.29B |
| Stockholders Equity | 31.84B | 29.66B | 28.50B | 28.49B | 27.12B | 25.24B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 10.57B | 2.59B | 9.06B | 5.32B | 1.60B |
| Operating Cash Flow | 0 | 10.97B | 3.00B | 9.52B | 6.09B | 2.15B |
| Investing Cash Flow | 0 | 414.00M | 389.00M | 4.00M | 833.00M | 642.00M |
| Financing Cash Flow | 0 | -6.12B | -6.10B | -6.56B | -6.13B | -7.03B |
Bayer Cropscience India Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BAYERCROP, the sentiment is Negative. The current price of 3349.25 is above the 20-day moving average (MA) of 3299.63, below the 50-day MA of 3484.24, and below the 200-day MA of 4060.15, indicating a neutral trend. The MACD of -20.81 indicates Negative momentum. The RSI at 47.06 is Neutral, neither overbought nor oversold. The STOCH value of 26.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BAYERCROP.
Bayer Cropscience India Limited Peers Comparison
Overall Rating
IN:BAYERCROP78Outperform
IN:DHANUKA73Outperform
IN:SHARDACROP73Outperform
IN:RALLIS63Neutral
IN:UPL63Neutral
IN:PIIND58Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 78Outperform | INR 150.52B | 20.18 | ― | 4.48% | -5.00% | 22.45% | |
| 73Outperform | INR 40.93B | 14.67 | ― | 0.22% | -0.06% | 0.75% | |
| 73Outperform | INR 60.59B | 9.41 | ― | 2.23% | 17.28% | 42.45% | |
| 63Neutral | INR 36.82B | 18.72 | ― | 1.59% | 6.82% | 11.93% | |
| 63Neutral | INR 480.33B | 25.47 | ― | 1.05% | 10.33% | -14.32% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 58Neutral | INR 248.06B | 28.16 | ― | 0.61% | -14.95% | -41.96% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:BAYERCROP | Bayer Cropscience India Limited | 3349.25 | -1012.74 | -23.22% | |
| IN:DHANUKA | Dhanuka Agritech Limited | 918.25 | -293.26 | -24.21% | |
| IN:PIIND | PI Industries Limited | 1635.00 | -1773.44 | -52.03% | |
| IN:RALLIS | Rallis India Limited | 189.35 | -57.69 | -23.35% | |
| IN:SHARDACROP | Sharda Cropchem Ltd. | 671.60 | -106.87 | -13.73% | |
| IN:UPL | UPL Limited | 569.00 | -166.58 | -22.65% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 28, 2026
